1. Home
  2. PACB vs SCM Comparison

PACB vs SCM Comparison

Compare PACB & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • SCM
  • Stock Information
  • Founded
  • PACB 2000
  • SCM 2012
  • Country
  • PACB United States
  • SCM United States
  • Employees
  • PACB N/A
  • SCM N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • SCM Finance/Investors Services
  • Sector
  • PACB Industrials
  • SCM Finance
  • Exchange
  • PACB Nasdaq
  • SCM Nasdaq
  • Market Cap
  • PACB 452.1M
  • SCM 370.0M
  • IPO Year
  • PACB 2010
  • SCM 2012
  • Fundamental
  • Price
  • PACB $2.42
  • SCM $13.89
  • Analyst Decision
  • PACB Buy
  • SCM Hold
  • Analyst Count
  • PACB 15
  • SCM 2
  • Target Price
  • PACB $3.79
  • SCM $13.63
  • AVG Volume (30 Days)
  • PACB 9.3M
  • SCM 151.7K
  • Earning Date
  • PACB 11-07-2024
  • SCM 11-07-2024
  • Dividend Yield
  • PACB N/A
  • SCM 11.52%
  • EPS Growth
  • PACB N/A
  • SCM 57.14
  • EPS
  • PACB N/A
  • SCM 1.28
  • Revenue
  • PACB $188,871,000.00
  • SCM $107,810,152.00
  • Revenue This Year
  • PACB N/A
  • SCM $2.75
  • Revenue Next Year
  • PACB $27.48
  • SCM $1.08
  • P/E Ratio
  • PACB N/A
  • SCM $10.78
  • Revenue Growth
  • PACB 29.24
  • SCM 14.49
  • 52 Week Low
  • PACB $1.16
  • SCM $12.43
  • 52 Week High
  • PACB $10.65
  • SCM $14.68
  • Technical
  • Relative Strength Index (RSI)
  • PACB 73.20
  • SCM 50.64
  • Support Level
  • PACB $2.38
  • SCM $13.43
  • Resistance Level
  • PACB $2.40
  • SCM $14.14
  • Average True Range (ATR)
  • PACB 0.20
  • SCM 0.20
  • MACD
  • PACB 0.07
  • SCM -0.05
  • Stochastic Oscillator
  • PACB 89.31
  • SCM 55.67

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. Business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

Share on Social Networks: